AC Immune reports positive preliminary Phase 1 data for ACI-19764
AC Immune says preliminary Phase 1 data for its NLRP3 inhibitor ACI-19764 are positive, with no further details on the findings supplied in the alert.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.